Advances in liver xenotransplantation

Area of Science:

• Transplantation immunology
• Xenotransplantation research
• Organ transplantation

Background:

• Pig to primate liver xenotransplantation models face challenges including thrombocytopenia, anemia, and coagulopathy.
• Platelet sequestration involves liver sinusoidal endothelial cells and Kupffer cells, partly via asialoglycoprotein receptor 1.
• Xenoantigens like N-glycolylneuraminic acid contribute to graft injury and red blood cell consumption.

Purpose of the Study:

• To review recent advances in liver xenotransplantation.
• To focus on immunologic barriers and mechanisms of graft failure and recipient demise.
• To discuss recent in-vivo results in liver xenotransplantation models.

Main Methods:

• Review of current literature on liver xenotransplantation.
• Analysis of cellular and molecular mechanisms underlying xenograft failure.
• Evaluation of in-vivo experimental outcomes in pig to primate models.

Main Results:

• Thrombocytopenia, anemia, and coagulopathy are key complications in pig to primate liver xenotransplantation.
• Mechanisms involving liver sinusoidal endothelial cells, Kupffer cells, and asialoglycoprotein receptor 1 mediate platelet sequestration.
• Genetic modifications and coagulation factor supplementation counteract coagulopathy, significantly increasing survival.

Conclusions:

• Increased understanding of cellular mechanisms has led to improved outcomes in in-vivo pig to primate liver xenotransplant models.
• Recent successes in overcoming immunologic barriers support the potential for initial clinical application of liver xenotransplantation.
• Further research into xenotransplantation mechanisms is crucial for advancing clinical viability.